These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34332922)

  • 1. Antioxidant effect of ascorbic acid against cisplatin-induced nephrotoxicity and P-glycoprotein expression in rats.
    Okamoto K; Kitaichi F; Saito Y; Ueda H; Narumi K; Furugen A; Kobayashi M
    Eur J Pharmacol; 2021 Oct; 909():174395. PubMed ID: 34332922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo.
    Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
    Eur J Pharmacol; 2020 Oct; 884():173339. PubMed ID: 32726655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain "gatekeeper" function.
    Takeda F; Oda M; Terasaki M; Ichimura Y; Kojima H; Saitoh H
    Toxicol Appl Pharmacol; 2021 Jul; 423():115570. PubMed ID: 33965372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
    Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
    Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters.
    Saito Y; Okamoto K; Kobayashi M; Narumi K; Yamada T; Iseki K
    Eur J Pharmacol; 2017 Sep; 811():191-198. PubMed ID: 28529140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender difference following high cholesterol diet induced renal injury and the protective role of rutin and ascorbic acid combination in Wistar albino rats.
    Al-Rejaie SS; Abuohashish HM; Alkhamees OA; Aleisa AM; Alroujayee AS
    Lipids Health Dis; 2012 Mar; 11():41. PubMed ID: 22423898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nephroprotective effects of allicin and ascorbic acid against cisplatin-induced toxicity in rats.
    Abdel-Daim MM; Abushouk AI; Donia T; Alarifi S; Alkahtani S; Aleya L; Bungau SG
    Environ Sci Pollut Res Int; 2019 May; 26(13):13502-13509. PubMed ID: 30911969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Administration of l-Carnitine and Ascorbic Acid Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
    Alabi QK; Akomolafe RO; Olukiran OS; Nafiu AO; Adefisayo MA; Owotomo OI; Omole JG; Olamilosoye KP
    J Am Coll Nutr; 2018 Jul; 37(5):387-398. PubMed ID: 29425480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
    Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
    Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
    PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the protection of growth hormone in cisplatin-induced nephrotoxicity: The impact of IGF-1 on the Keap1-Nrf2/HO-1 signaling.
    Mahran YF
    Life Sci; 2020 Jul; 253():117581. PubMed ID: 32209424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity.
    Abdel-Daim MM; Aleya L; El-Bialy BE; Abushouk AI; Alkahtani S; Alarifi S; Alkahtane AA; AlBasher G; Ali D; Almeer RS; Al-Sultan NK; Alghamdi J; Alahmari A; Bungau SG
    Environ Sci Pollut Res Int; 2019 May; 26(15):15248-15254. PubMed ID: 30929167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pomegranate seed extract attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in rats.
    Cayır K; Karadeniz A; Simşek N; Yıldırım S; Karakuş E; Kara A; Akkoyun HT; Sengül E
    J Med Food; 2011 Oct; 14(10):1254-62. PubMed ID: 21548807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.
    Nakagawa T; Kakizoe Y; Iwata Y; Miyasato Y; Mizumoto T; Adachi M; Izumi Y; Kuwabara T; Suenaga N; Narita Y; Jono H; Saito H; Kitamura K; Mukoyama M
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1347-F1357. PubMed ID: 30043627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds.
    Hannemann J; Duwe J; Baumann K
    Cancer Chemother Pharmacol; 1991; 28(6):427-33. PubMed ID: 1934247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.
    Jilek JL; Frost KL; Jacobus KA; He W; Toth EL; Goedken M; Cherrington NJ
    Acta Pharm Sin B; 2021 Dec; 11(12):3869-3878. PubMed ID: 35024313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
    Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.